# Centre Hospitalier Universitaire de Nantes

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/centre-hospitalier-universitaire-de-nantes/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 56.8 |
| Citations | 1,157,995 |
| City | Nantes |
| Country | FR |
| Description | Centre Hospitalier Universitaire de Nantes is a research organisation in Nantes, FR. OpenAlex records 20,878 works and 1,157,995 citations for it. 4,458 researchers list it as their most recent affiliation. |
| Homepage | http://www.chu-nantes.fr/ |
| OpenAlex ID | https://openalex.org/I3019204325 |
| Region | Pays de la Loire |
| Researchers | 4,458 |
| ROR ID | https://ror.org/05c1qsg97 |
| Type | healthcare |
| Works | 20,878 |

## University papers

Showing 12 of 20.

- [Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations](https://scholariq.org/papers/phase-iii-study-of-afatinib-or-cisplatin-plus-pemetrexed-in-patients-with/)
- [Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials](https://scholariq.org/papers/afatinib-versus-cisplatin-based-chemotherapy-for-egfr-mutation-positive-lung/)
- [Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer](https://scholariq.org/papers/randomized-phase-iii-keynote-181-study-of-pembrolizumab-versus-chemotherapy-in/)
- [Hydrocortisone plus Fludrocortisone for Adults with Septic Shock](https://scholariq.org/papers/hydrocortisone-plus-fludrocortisone-for-adults-with-septic-shock/)
- [Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial](https://scholariq.org/papers/carboplatin-and-weekly-paclitaxel-doublet-chemotherapy-compared-with-monotherapy/)
- [Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial](https://scholariq.org/papers/sodium-bicarbonate-therapy-for-patients-with-severe-metabolic-acidaemia-in-the/)
- [Utility of hyposmia and hypogeusia for the diagnosis of COVID-19](https://scholariq.org/papers/utility-of-hyposmia-and-hypogeusia-for-the-diagnosis-of-covid-19/)
- [Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study](https://scholariq.org/papers/datopotamab-deruxtecan-versus-docetaxel-for-previously-treated-advanced-or/)
- [Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial](https://scholariq.org/papers/three-versus-6-months-of-oxaliplatin-based-adjuvant-chemotherapy-for-patients/)
- [Outcome of acute mesenteric ischemia in the intensive care unit: a retrospective, multicenter study of 780 cases](https://scholariq.org/papers/outcome-of-acute-mesenteric-ischemia-in-the-intensive-care-unit-a-retrospective/)
- [Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial](https://scholariq.org/papers/afatinib-beyond-progression-in-patients-with-non-small-cell-lung-cancer/)
- [Prognostic performance of early absence of pupillary light reaction after recovery of out of hospital cardiac arrest](https://scholariq.org/papers/prognostic-performance-of-early-absence-of-pupillary-light-reaction-after/)

## University researchers

- [J. Jenvrin](https://scholariq.org/researchers/j-jenvrin/)

## University top topics

Showing 8 of 25.

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Health, Medicine and Society](https://scholariq.org/topics/health-medicine-and-society/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Pelvic floor disorders treatments](https://scholariq.org/topics/pelvic-floor-disorders-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.